In consideration of the lack of success of the clinical trials targeting brain accumulation of Aβ42 and hyperphosphorylated tau, a better knowledge of the role of TREM2 in the microglia functional states is expected to advance our understanding of the TREM2–AD relation. The gene discussed is MAPT; the disease is Alzheimer disease.